Alcohol-Related Liver Disease: Areas of Consensus, Unmet Needs and Opportunities for Further Study.


Journal

Hepatology (Baltimore, Md.)
ISSN: 1527-3350
Titre abrégé: Hepatology
Pays: United States
ID NLM: 8302946

Informations de publication

Date de publication:
05 2019
Historique:
received: 24 07 2018
accepted: 31 10 2018
pubmed: 16 1 2019
medline: 17 6 2020
entrez: 16 1 2019
Statut: ppublish

Résumé

A joint meeting of the European Association for the Study of the Liver (EASL) and the American Association for the Study of Liver Diseases (AASLD) was held in London on September 30 and October 1, 2017. The goals of the meeting were to identify areas of broad agreement and disagreement, develop consensus, and determine future directions to ultimately reduce the burden, morbidity, and mortality of alcohol-related liver disease (previously termed alcoholic liver disease). The specific aims of the meeting were to identify unmet needs and areas for future investigation, in order to reduce alcohol consumption, develop markers for diagnosis and prognosis of disease, and create a framework to test novel pharmacological agents with pre-specified treatment endpoints. A table summary of these goals and aims is provided in the context of epidemiology, current management strategies, next steps for future trials and translational science.

Identifiants

pubmed: 30645002
doi: 10.1002/hep.30369
doi:

Substances chimiques

Biomarkers 0

Types de publication

Congress Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2271-2283

Subventions

Organisme : Medical Research Council
ID : MR/R014019/1
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : UM1 CA186107
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA087969
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA167552
Pays : United States

Investigateurs

Giovanni Addolorato (G)
Ramon Bataller (R)
Patrizia Burra (P)
Laurent Castera (L)
Helena Cortez Pinto (H)
Anna Mae Diehl (AM)
Bin Gao (B)
Sir Ian Gilmore (SI)
Jochen Hampe (J)
Rehm Jürgen (R)
Michael Karin (M)
Alexander Krag (A)
David Leon (D)
Christopher Leptak (C)
Alexandre Louvet (A)
Michael Lucey (M)
Craig McClain (C)
Laura Nagy (L)
Georges-Philippe Pageaux (GP)
Arun Sanyal (A)
Bernd Schnabl (B)
Dina Tiniakos (D)
Christian Trautwein (C)
Hidekazu Tsukamoto (H)

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2019 by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver.

Auteurs

Gyongyi Szabo (G)

Department of Medicine, University of Massachusetts Medical School, Worcester, MA, US.

Patrick S Kamath (PS)

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN, US.

Vijay H Shah (VH)

Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN, US.

Mark Thursz (M)

Digestive Diseases Division, Department of Surgery & Cancer, Imperial College, London, UK.

Philippe Mathurin (P)

Service des Maladies de l'Appareil Digestif, Hôpital Claude Huriez, Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH